Insight Molecular Diagnostics Inc. Ratios

Ratios Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin -52.55%64.60%-1.88%27.48%39.34%
EBT Margin -2,564.64%-2,405.41%-1,942.80%-1,672.39%-3,245.14%
EBIT Margin -2,443.34%-2,444.27%-1,878.60%-1,672.39%-3,245.14%
EBITDA Margin -2,443.34%-2,444.27%-1,878.60%-1,672.39%-3,245.14%
Operating Margin -2,443.34%-2,444.27%-1,878.60%-1,672.39%-3,245.14%
Net Margin -2,457.73%-2,916.15%-7,664.09%-194.68%-3,245.14%
FCF Margin -2,237.42%-1,737.40%-5,209.60%-1,570.59%-1,128.60%
Efficiency
Assets Average 107.49M129.83M87.49M54.99M
Equity Average 49.35M49.75M27.38M4.10M
Invested Capital 35.87M66.61M34.40M22.78M-12.05M
Asset Utilization Ratio 0.020.010.020.03
Leverage & Solvency
Debt to Equity 0.120.020.000.11-0.02
Debt Ratio 0.070.010.000.030.01
Equity Ratio 0.600.410.340.27-0.35
Valuation
Enterprise Value 202.40M146.14M56.12M116.94M152.91M166.29M20.67M13.32M31.43M
Market Capitalization 202.40M146.14M56.12M116.94M160.73M200.14M41.09M22.75M40.07M
Return Ratios
Return on Sales -24.58%-9.32%-56.67%-1.95%-32.45%
Return on Capital Employed -0.58%-0.15%-0.31%-1.28%
Return on Invested Capital -0.86%-0.20%
Return on Assets -0.19%-0.42%-0.03%-1.11%
Return on Equity -0.42%-1.09%-0.11%-14.90%